Combination Chemotherapy With or Without Prednisone in Treating Patients With Recurrent and/or Metastatic Kidney Cancer

Part of paid clinical trials in Albuquerque, New Mexico.

Sponsor
University of New Mexico
Study ID
NCT00003584
Phase
PHASE2
Status
Completed

Conditions

Eligibility Criteria

Sex
ALL
Age
N/A - 120 Years
Healthy Volunteers
Not accepted

Interventions

Study Details

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. Prednisone may help to relieve symptoms in patients with recurrent and/or metastatic kidney cancer. PURPOSE: Phase II trial to study the effectiveness of combination chemotherapy consisting of vinorelbine and estramustine with or without prednisone in treating patients who have recurrent and/or metastatic kidney cancer.

Key Dates

Start date
Jul 31, 1998
Status verified
May 2016
Primary completion
Dec 31, 2000
Completion
Dec 31, 2000

Study Design

Enrollment
35 participants (estimated)
Primary purpose
TREATMENT

Locations (1)

FacilityCityStateZIPSite coordinators
University of New Mexico Cancer Research & Treatment CenterAlbuquerqueNew Mexico87131-

Find similar trials in Albuquerque, NM

By condition
Kidney cancer
By specialty
OncologyUrology
By research site
University of New Mexico Cancer Research & Treatment Center· Albuquerque, NM

Related Studies